ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Bartley P. Griffith
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Griffith, B. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Griffith, B. P.
Related Collections
Right arrow History

Ann Thorac Surg 2003;76:S2254-S2259
© 2003 The Society of Thoracic Surgeons


Supplement: Gibbon & His Heart-Lung Machine

Surgical treatment of congestive heart failure: evolving options

Bartley P. Griffith, MDa*

a Division of Cardiac Surgery, University of Maryland, Baltimore, Maryland, USA

* Address reprint requests to Dr Griffith, Division of Cardiac Surgery, University of Maryland, N4W94, 22 S Greene St, Baltimore, MD 21201, USA
e-mail: bgriffith@smail.umaryland.edu

Presented at the symposium, "Gibbon & His Heart-Lung Machine: 50 Years & Beyond," Philadelphia, PA, May 2, 2003.

The first 300 words of the full text of this article appear below.

I am most pleased to be included in this wonderful symposium to honor John Gibbon and his contributions to cardiopulmonary bypass. It is special to me as a graduate of Jefferson Medical College to discuss surgical treatment of congestive heart failure as I have formed much of my interest in the areas that intrigued Dr Gibbon. Since leaving this school I have had unbridled opportunities to research and clinically explore extracorporeal membrane oxygenation, heart and lung transplantation, and mechanical circulatory support. It is important to review the current trends in surgical management because congestive heart failure afflicts more than 4.9 million Americans and consumes more than 5% of the total US health care dollars ($40 billion) [1]. Our specialty's response to the need is critical for those suffering and for cardiac surgeons who adapt to nonsurgical advances in coronary artery disease. My discussion will include the role for myocardial revascularization, mitral valve repair, left ventricular remodeling, mechanical circulatory support, and transplantation for those with heart failure.

Patients are often referred for consideration of revascularization when they have considerable left ventricular dysfunction based on established trials [2–5]. In the past much attention has been focused on the factors that influence surgical mortality [6–16]. These include quality of surgical targets, symptomatic status of the patient, level of pulmonary artery pressure, acuteness of presentation, and overall state of the patient at presentation. Surgical mortality is now an acceptable 2.3% to 5.0%. However a number of patients have been referred to us for consideration of transplantation when they have severely depressed left ventricular function and with unclear viability. The assessment of myocardial viability has improved and now permits the differentiation of myocardial fibrosis from hibernation [17, 18]. In the latter, coronary revascularization . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
CirculationHome page
Writing Committee Members, G. S. Francis, B. H. Greenberg, D. T. Hsu, B. E. Jaski, M. Jessup, M. M. LeWinter, F. D. Pagani, I. L. Pina, M. J. Semigran, et al.
ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant: A Report of the ACCF/AHA/ACP Task Force on Clinical Competence and Training
Circulation, August 10, 2010; 122(6): 644 - 672.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. S. Francis, B. H. Greenberg, D. T. Hsu, B. E. Jaski, M. Jessup, M. M. LeWinter, F. D. Pagani, I. L. Pina, M. J. Semigran, M. N. Walsh, et al.
ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant: A Report of the ACCF/AHA/ACP Task Force on Clinical Competence and Training
J. Am. Coll. Cardiol., July 27, 2010; 56(5): 424 - 453.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Marui, T. Nishina, Y. Saji, K. Yamazaki, T. Shimamoto, T. Ikeda, and R. Sakata
Significance of Left Ventricular Diastolic Function on Outcomes After Surgical Ventricular Restoration
Ann. Thorac. Surg., May 1, 2010; 89(5): 1524 - 1531.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. Burkhoff and A. S. Wechsler
Surgical ventricular remodeling: A balancing act on systolic and diastolic properties.
J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 459 - 463.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The Society of Thoracic Surgeons.